Diabetes & CV Disease
Sort by:
Icahn School of Medicine at Mount Sinai
Nicotine Addiction: Unexpected Cells, Circuits, and Sicknesses
FEATURING
Paul Kenny
- 31 views
- May 18, 2021
Complex Coronary Cases
Implication of Emerging Cardiac Medications
FEATURING
Thomas Geramita
- 10 views
- July 19, 2024
Icahn School of Medicine at Mount Sinai
Kidney Week 2022: Cell-to-Cell Chats in the Diabetic Kidney Endothelial Cells to Podocytes and Back
FEATURING
Ilse Daehn
- 102 views
- March 15, 2023
Peter Nilsson
Recent Diabetes CVD Trials on SGLT2 and GLP1 and their Effects on Body Weight and Hypertension
- 5 views
- September 16, 2024
Devada Singh
Hypoglycemia Treatment: What Are the Benchmarks For Levels of Severity and What Are Their Treatment Options?
FEATURING
Cynthia Moreau
- 34 views
- May 13, 2021
Emory Diabetes Education Training Academy
Understanding Oral and Injectable Therapy Options for T2D Care
FEATURING
Sol Jacobs
- 113 views
- April 28, 2021
Emory Diabetes Education Training Academy
Evolution of SGLT2-Inhibitors and GLP1-RA's Relating to Macrovascular Outcomes
FEATURING
Francisco Pasquel
- 106 views
- April 26, 2021
NutritionFacts.org
Why Is Meat a Risk Factor for Diabetes?
FEATURING
Michael Greger
- 77 views
- October 3, 2017
Emory Diabetes Education Training Academy
SGLT2-i Impact on Renal or HF Outcomes: What Is Observed in Non-Diabetic Patients?
FEATURING
Francisco Pasquel
- 264 views
- April 26, 2021
Houston Methodist Hospital
Who is Not Optimally Benefitting From Our Stroke Therapies and What Can We Do About It?
FEATURING
Thomas Kent
- 103 views
- May 11, 2023
ARCH Advanced Revascularization Symposium
Advanced Heart Failure Therapies: Update
FEATURING
Douglas Horstmanshof
- 210 views
- May 12, 2023
Mayo Clinic Proceedings
Association of Healthy Lifestyles with CV Disease in Diabetes
FEATURING
Yan-Bo Zhang
- 58 views
- June 9, 2023